TheProfitWatch

FDMT - 4D Molecular Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.3 0.59 (5.73%) 0.01 (0.09%) 0.01 (0.09%) -0.04 (-0.37%) 0.02 (0.19%) 0.59 (5.73%) 0.0 (0.0%) 0.12 (1.18%)

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.98
Diluted EPS:
-0.98
Basic P/E:
-11.1122
Diluted P/E:
-11.1122
RSI(14) 1m:
50.0
VWAP:
10.88
RVol:

Events

Period Kind Movement Occurred At

Related News